Left ventricular myocardial work combined with stress echocardiography assessment of cardiac function in patients with Fabry disease

Hong Zhou(Academy of Military Medical Sciences), Hongning Yin(Qingdao University of Science and Technology), Jingchao Lu(Hebei Medical University), Zijie Guo(Tianjin First Center Hospital), Weiyun Z. Ai(City College of San Francisco), Songyun Zhang(Hebei Medical University), Yajing Miao(Hebei Medical University)
Scientific Reports
November 21, 2025
10.1038/s41598-025-25382-w
Cited by 0

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
|Journal of Clinical Oncology|2010|487
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2021|428
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2013|247